XPO1 inhibition strongly sensitizes to first-line and second-line therapy in small cell lung cancer Meeting Abstract


Authors: Quintanal‐Villalonga, Á.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Chan, J. M.; Offin, M.; Ciampricotti, M.; Egger, J.; Qiu, J.; De Stanchina, E.; Hollmann, T. J.; Koche, R. P.; Sen, T.; Poirier, J. T.; Rudin, C. M.
Abstract Title: XPO1 inhibition strongly sensitizes to first-line and second-line therapy in small cell lung cancer
Meeting Title: Molecular Analysis for Precision Oncology Virtual Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 6
Meeting Dates: 2021 Oct 7-9
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-10-01
Start Page: S1345
Language: English
ACCESSION: WOS:000706622600003
DOI: 10.1016/j.annonc.2021.08.1998
PROVIDER: wos
Notes: Meeting Abstract: 2MO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Travis Jason Hollmann
    126 Hollmann
  2. Charles Rudin
    488 Rudin
  3. Richard Patrick Koche
    173 Koche
  4. Nisargbhai Sanjaykumar Shah
    29 Shah
  5. Joseph Minhow Chan
    48 Chan
  6. Juan   Qiu
    24 Qiu
  7. Viola   Allaj
    29 Allaj
  8. Michael David Offin
    170 Offin
  9. Andrew Chow
    45 Chow
  10. Jacklynn V Egger
    68 Egger
  11. Triparna Sen
    56 Sen
  12. Fathema Zannath Uddin
    22 Uddin
  13. Yingqian Zhan
    35 Zhan
  14. Parvathy Manoj
    34 Manoj